BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$3.96 +0.04 (+1.15%)
As of: Sep 30, 2026 · 12:25 PM EDT

BridgeBio Oncology Therapeutics, Inc. (BBOT) Accounts Payables (2024 - 2026)

Updated

BridgeBio Oncology Therapeutics (BBOT) posted Accounts Payables of $6.73 million for Q2 2026, up 166.7% from $2.52 million a year earlier but down 44.4% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics, Inc. (BBOT) Accounts Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Oncology Therapeutics' Accounts Payables came in at $1.37 million, down 55.3% from FY2024.

  • In prior years, BridgeBio Oncology Therapeutics' Accounts Payables was $3.07 million in FY2024.
  • Quarterly Accounts Payables has run from a low of $9,687 in Q1 2024 to a high of $12.09 million in Q1 2026 over five years.
  • According to Business Quant data, Accounts Payables for the three prior quarters was $12.09 million (Q1 2026), $1.37 million (Q4 2025) and $3.65 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.73 Mn
Mar 31, 2026 12.09 Mn
Dec 31, 2025 1.37 Mn
Sep 30, 2025 3.65 Mn
Jun 30, 2025 2.52 Mn
Dec 31, 2024 3.07 Mn
Mar 31, 2024 9,687.00
API Access

BridgeBio Oncology Therapeutics, Inc. Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=BBOT&period=max&api_key=YOUR_API_KEY